SG11202112994WA - SMALL MOLECULE INHIBITORS OF NF-kB INDUCING KINASE - Google Patents
SMALL MOLECULE INHIBITORS OF NF-kB INDUCING KINASEInfo
- Publication number
- SG11202112994WA SG11202112994WA SG11202112994WA SG11202112994WA SG11202112994WA SG 11202112994W A SG11202112994W A SG 11202112994WA SG 11202112994W A SG11202112994W A SG 11202112994WA SG 11202112994W A SG11202112994W A SG 11202112994WA SG 11202112994W A SG11202112994W A SG 11202112994WA
- Authority
- SG
- Singapore
- Prior art keywords
- small molecule
- molecule inhibitors
- inducing kinase
- kinase
- inducing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4365—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system having sulfur as a ring hetero atom, e.g. ticlopidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962855144P | 2019-05-31 | 2019-05-31 | |
| US201962907833P | 2019-09-30 | 2019-09-30 | |
| PCT/EP2020/065024 WO2020239999A1 (en) | 2019-05-31 | 2020-05-29 | SMALL MOLECULE INHIBITORS OF NF-kB INDUCING KINASE |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11202112994WA true SG11202112994WA (en) | 2021-12-30 |
Family
ID=71108552
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11202112994WA SG11202112994WA (en) | 2019-05-31 | 2020-05-29 | SMALL MOLECULE INHIBITORS OF NF-kB INDUCING KINASE |
Country Status (22)
| Country | Link |
|---|---|
| US (2) | US11254673B2 (en) |
| EP (1) | EP3976597A1 (en) |
| JP (1) | JP2022534302A (en) |
| KR (1) | KR20220027871A (en) |
| CN (1) | CN114222737A (en) |
| AU (1) | AU2020282005A1 (en) |
| BR (1) | BR112021023796A2 (en) |
| CA (1) | CA3143350A1 (en) |
| CL (1) | CL2021003142A1 (en) |
| CO (1) | CO2021017838A2 (en) |
| CR (1) | CR20210587A (en) |
| DO (1) | DOP2021000244A (en) |
| EC (1) | ECSP21093623A (en) |
| IL (1) | IL288387A (en) |
| JO (1) | JOP20210318A1 (en) |
| MA (1) | MA56038A (en) |
| MX (1) | MX2021014679A (en) |
| PE (1) | PE20220768A1 (en) |
| SG (1) | SG11202112994WA (en) |
| TW (1) | TW202110842A (en) |
| UY (1) | UY38721A (en) |
| WO (1) | WO2020239999A1 (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG11202113154YA (en) | 2019-05-31 | 2021-12-30 | Ikena Oncology Inc | Tead inhibitors and uses thereof |
| AU2020282005A1 (en) * | 2019-05-31 | 2021-12-23 | Janssen Pharmaceutica Nv | Small molecule inhibitors of NF-kB inducing kinase |
| WO2023217906A1 (en) * | 2022-05-11 | 2023-11-16 | Janssen Pharmaceutica Nv | Pyrrolidinone derivatives as inhibitors of nf kappa b inducing kinase |
| WO2023217879A1 (en) * | 2022-05-11 | 2023-11-16 | Janssen Pharmaceutica Nv | Pyrrolidione derivatives as inhibitors of nf kappa b inducing kinase |
Family Cites Families (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9930616D0 (en) | 1999-12-24 | 2000-02-16 | Mathilda & Terence Kennedy Ins | Activation and inhibition of the immune system |
| US7132428B2 (en) | 2003-07-03 | 2006-11-07 | Aventis Pharmaceuticals Inc. | Pyrazoloisoquinoline derivative as kinase inhibitors for the treatment of various disorders |
| CN101213194A (en) * | 2004-08-03 | 2008-07-02 | 惠氏公司 | Indazoles useful in treating cardiovascular diseases |
| JP4964780B2 (en) | 2004-11-12 | 2012-07-04 | スタッツ・チップパック・インコーポレイテッド | Wire bond interconnect, semiconductor package, and method of forming wire bond interconnect |
| WO2009158011A1 (en) * | 2008-06-26 | 2009-12-30 | Amgen Inc. | Alkynyl alcohols as kinase inhibitors |
| US20110183975A1 (en) | 2008-10-07 | 2011-07-28 | Yasuhiro Goto | Novel 6-azaindole aminopyrimidine derivatives having nik inhibitory activity |
| KR20130133051A (en) * | 2011-03-16 | 2013-12-05 | 에프. 호프만-라 로슈 아게 | 6,5-heterocyclic propargylic alcohol compounds and uses therefor |
| KR20140131359A (en) * | 2012-02-17 | 2014-11-12 | 에프. 호프만-라 로슈 아게 | Tricyclic compounds and methods of use therefor |
| TWI663166B (en) | 2013-04-24 | 2019-06-21 | 健生藥品公司 | New compounds |
| TW201542520A (en) | 2013-08-22 | 2015-11-16 | Hoffmann La Roche | Alkynyl alcohols and methods of use |
| TW201512173A (en) * | 2013-08-22 | 2015-04-01 | Hoffmann La Roche | Alkynyl alcohols and methods of use |
| TWI627173B (en) | 2013-09-26 | 2018-06-21 | 比利時商健生藥品公司 | New 3-(1h-pyrazol-4-yl)-1h-pyrrolo[2,3-c]pyridine derivatives as nik inhibitors |
| TWI704146B (en) | 2013-09-26 | 2020-09-11 | 比利時商健生藥品公司 | NEW 1-(4-PYRIMIDINYL)-1H-PYRROLO[3,2-c]PYRIDINE DERIVATIVES AS NIK INHIBITORS |
| US10005776B2 (en) | 2014-10-23 | 2018-06-26 | Janssen Pharmaceutica Nv | Compounds as NIK inhibitors |
| BR112017008039B1 (en) | 2014-10-23 | 2023-04-11 | Janssen Pharmaceutica N.V. | PYRAZOLE DERIVATIVES AS NIK INHIBITORS, THEIR USE IN THE TREATMENT OR PREVENTION OF CANCER AND THE PHARMACEUTICAL COMPOSITION INCLUDING THEM |
| US10323045B2 (en) | 2014-10-23 | 2019-06-18 | Janssen Pharmaceutica Nv | Thienopyrimidine derivatives as NIK inhibitors |
| WO2016062790A1 (en) | 2014-10-23 | 2016-04-28 | Janssen Pharmaceutica Nv | New pyrazolopyrimidine derivatives as nik inhibitors |
| JP2018510140A (en) | 2015-02-25 | 2018-04-12 | エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ | Alkynyl alcohol and method of use |
| DK3405196T3 (en) | 2016-01-22 | 2020-03-09 | Janssen Pharmaceutica Nv | Nye substituerede cyanoindolinderivater som nik-inhibitorer |
| KR20180098679A (en) | 2016-01-22 | 2018-09-04 | 잔센파마슈티카엔.브이. | New 6-membered heteroaromatic substituted cyanoindoline derivatives as NIK inhibitors |
| EP3478675B1 (en) | 2016-06-30 | 2020-04-22 | Janssen Pharmaceutica NV | Heteroaromatic derivatives as nik inhibitors |
| EP3478673B1 (en) | 2016-06-30 | 2020-09-16 | Janssen Pharmaceutica NV | Cyanoindoline derivatives as nik inhibitors |
| CN109641894B (en) | 2016-08-24 | 2022-09-09 | 豪夫迈·罗氏有限公司 | 2-azabicyclo [3.1.0] hex-3-one derivatives and methods of use |
| JP7138093B2 (en) * | 2016-08-24 | 2022-09-15 | エフ．ホフマン－ラ ロシュ アーゲー | 2-azabicyclo[3.1.0]hexan-3-one derivative and method of use |
| AU2018297592B2 (en) | 2017-07-06 | 2021-12-16 | Janssen Pharmaceutica Nv | New substituted azaindoline derivatives as NIK inhibitors |
| CN109810110B (en) * | 2017-11-22 | 2023-01-24 | 中国科学院上海药物研究所 | Compound with 2-aminopyrimidine structure, preparation method and application thereof |
| BR112021024033A2 (en) | 2019-05-31 | 2022-02-08 | Sage Therapeutics Inc | Neuroactive steroids and their compositions |
| EP3976194A2 (en) | 2019-05-31 | 2022-04-06 | Ikena Oncology, Inc. | Tead inhibitors and uses thereof |
| SG11202113154YA (en) | 2019-05-31 | 2021-12-30 | Ikena Oncology Inc | Tead inhibitors and uses thereof |
| WO2020239951A1 (en) | 2019-05-31 | 2020-12-03 | Chiesi Farmaceutici S.P.A. | Amino quinazoline derivatives as p2x3 inhibitors |
| AU2020282005A1 (en) * | 2019-05-31 | 2021-12-23 | Janssen Pharmaceutica Nv | Small molecule inhibitors of NF-kB inducing kinase |
| AR120109A1 (en) | 2019-09-30 | 2022-02-02 | Incyte Corp | PYRIDO[3,2-D]PYRIMIDINE COMPOUNDS AS IMMUNOMODULATORS |
-
2020
- 2020-05-29 AU AU2020282005A patent/AU2020282005A1/en active Pending
- 2020-05-29 SG SG11202112994WA patent/SG11202112994WA/en unknown
- 2020-05-29 WO PCT/EP2020/065024 patent/WO2020239999A1/en active Application Filing
- 2020-05-29 US US16/887,889 patent/US11254673B2/en active Active
- 2020-05-29 CN CN202080057418.XA patent/CN114222737A/en active Pending
- 2020-05-29 JP JP2021570919A patent/JP2022534302A/en active Pending
- 2020-05-29 MX MX2021014679A patent/MX2021014679A/en unknown
- 2020-05-29 EP EP20733688.4A patent/EP3976597A1/en active Pending
- 2020-05-29 CR CR20210587A patent/CR20210587A/en unknown
- 2020-05-29 BR BR112021023796A patent/BR112021023796A2/en unknown
- 2020-05-29 JO JOP/2021/0318A patent/JOP20210318A1/en unknown
- 2020-05-29 PE PE2021001987A patent/PE20220768A1/en unknown
- 2020-05-29 MA MA056038A patent/MA56038A/en unknown
- 2020-05-29 CA CA3143350A patent/CA3143350A1/en active Pending
- 2020-05-29 UY UY0001038721A patent/UY38721A/en unknown
- 2020-05-29 TW TW109118004A patent/TW202110842A/en unknown
- 2020-05-29 KR KR1020217042635A patent/KR20220027871A/en unknown
-
2021
- 2021-11-25 CL CL2021003142A patent/CL2021003142A1/en unknown
- 2021-11-25 IL IL288387A patent/IL288387A/en unknown
- 2021-11-26 DO DO2021000244A patent/DOP2021000244A/en unknown
- 2021-12-13 US US17/549,057 patent/US11827634B2/en active Active
- 2021-12-27 CO CONC2021/0017838A patent/CO2021017838A2/en unknown
- 2021-12-28 EC ECSENADI202193623A patent/ECSP21093623A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP3976597A1 (en) | 2022-04-06 |
| CL2021003142A1 (en) | 2022-08-19 |
| WO2020239999A1 (en) | 2020-12-03 |
| DOP2021000244A (en) | 2022-04-18 |
| IL288387A (en) | 2022-01-01 |
| US20230080834A1 (en) | 2023-03-16 |
| US11254673B2 (en) | 2022-02-22 |
| PE20220768A1 (en) | 2022-05-16 |
| CO2021017838A2 (en) | 2022-01-17 |
| BR112021023796A2 (en) | 2022-02-08 |
| CA3143350A1 (en) | 2020-12-03 |
| AU2020282005A1 (en) | 2021-12-23 |
| CN114222737A (en) | 2022-03-22 |
| MA56038A (en) | 2022-04-06 |
| JOP20210318A1 (en) | 2023-01-30 |
| MX2021014679A (en) | 2022-04-06 |
| JP2022534302A (en) | 2022-07-28 |
| CR20210587A (en) | 2022-02-11 |
| US11827634B2 (en) | 2023-11-28 |
| ECSP21093623A (en) | 2022-01-31 |
| TW202110842A (en) | 2021-03-16 |
| UY38721A (en) | 2020-11-30 |
| KR20220027871A (en) | 2022-03-08 |
| US20210300918A1 (en) | 2021-09-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL292642A (en) | Ras inhibitors | |
| IL292643A (en) | Ras inhibitors | |
| IL292644A (en) | Ras inhibitors | |
| IL288387A (en) | Small molecule inhibitors of nf-kb inducing kinase | |
| GB202001344D0 (en) | Ras Inhibitors | |
| EP4069212A4 (en) | Inhibitors of hif-2alpha | |
| IL276269A (en) | Aminopyrrolotriazines as kinase inhibitors | |
| SI3700902T1 (en) | Inhibitors of trpc6 | |
| IL268614A (en) | Aminotriazolopyridines as kinase inhibitors | |
| ZA202203770B (en) | Pharmaceutical combination of prmt5 inhibitors | |
| IL270693A (en) | Glucuronide prodrugs of janus kinase inhibitors | |
| IL308193A (en) | Ras inhibitors | |
| KR20220035925A (en) | Substituted 2-morpholinopyridine derivatives as ATR kinase inhibitors | |
| IL274207B (en) | Aminoimidazopyridazines as kinase inhibitors | |
| IL264593A (en) | Pharmaceutical compositions comprising akt protein kinase inhibitors | |
| IL279314A (en) | Small molecule inhibitors of the jak family of kinases | |
| EP3927700A4 (en) | Kinase inhibitors | |
| EP3986411A4 (en) | Small molecule inhibitors of src tyrosine kinase | |
| IL281599A (en) | Tyk2 kinase inhibitors | |
| EP3476848A4 (en) | Benzofuran pyrazole amine protein kinase inhibitor | |
| SG10201909596RA (en) | Synthesis of Tyrosine Kinase Inhibitors | |
| EP3999064A4 (en) | Inhibitors of tyrosine kinase | |
| IL277869A (en) | Substituted propanamides as inhibitors of nucleases | |
| ZA201908372B (en) | Pyridoquinazoline derivatives useful as protein kinase inhibitors | |
| GB201807845D0 (en) | Kinase Inhibitors |